{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T02:35:40Z","timestamp":1779935740875,"version":"3.53.1"},"reference-count":58,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2024,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>Previous literature has investigated opioid prescription trends in ophthalmology at large, however, little has been done looking at differences between subspecialties. We evaluate if significant trends exist among subspecialties in opioid prescribing patterns. This study aims to illuminate potential over-usage of opioids in ophthalmology that could compromise patient quality of life.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Medicare data and \u201cNational Plan and Provider Enumeration System (NPPES) Downloadable File\u201d were queried for cases of ophthalmologists with nonsuppressed opioid prescription data from 2014 to 2019. Ophthalmologists with no subspecialty code or missing regional, gender, degree, or graduation information were excluded. Chi-squared analysis, analysis of variance,\n                      <jats:italic toggle=\"yes\">t<\/jats:italic>\n                      -tests, and multivariate logistic regression were utilized.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Five thousand one hundred forty-three physician records were included in analysis, 450 of which were by cornea subspecialists. Most cornea cases were male, graduated before 2005, and practiced in the South. All subspecialties had a significantly increased likelihood of making opioid claims and higher prescription rates compared with cornea (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.050) besides glaucoma (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.357). Only oculoplastics had significantly increased likelihood of greater total supply of opioids compared with cornea (odds ratio [OR]\u2009=\u200922.195, 95% confidence interval [CI]\u2009=\u200912.209\u201340.350,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.001), while pediatrics (OR\u2009=\u20094.036, 95% CI\u2009=\u20091.377\u201311.831,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.011) and neuro-ophthalmology (OR\u2009=\u20094.158, 95% CI\u2009=\u20091.237\u201313.975,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u20090.021) in addition to oculoplastics (OR\u2009=\u200964.380, 95% CI\u2009=\u200926.306\u2013157.560,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.001) were predicted to have significantly greater opioid beneficiaries. Males, the South\/Midwest, and graduating before 2005, all were generally associated with increased likelihood of greater total opioid claims, supply, beneficiaries, and prescription rate (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&lt;\u20090.050).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Subspecialty, demographic, chronological, and regional trends exist for opioid prescribing patterns in ophthalmology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1089\/jop.2023.0078","type":"journal-article","created":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T11:45:57Z","timestamp":1698234357000},"page":"34-47","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Interspecialty Opioid Prescribing Patterns in Ophthalmology Following Declaration of a Public Health Emergency"],"prefix":"10.1177","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4321-7536","authenticated-orcid":false,"given":"Hassaam S.","family":"Choudhry","sequence":"first","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aman M.","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aretha","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1704-0431","authenticated-orcid":false,"given":"Sri","family":"Guttikonda","sequence":"additional","affiliation":[{"name":"Rutgers The State University of New Jersey, Piscataway, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anam","family":"Shaikh","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadeel S.","family":"Sadek","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher W.","family":"Seery","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."},{"name":"Bascom Palmer Eye Institute at the University of Miami, Coral Gables, Florida, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad H.","family":"Dastjerdi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology and Visual Science at Rutgers New Jersey Medical School, Newark, New Jersey, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,2,9]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1710862"},{"key":"e_1_3_4_3_2","unstructured":"Prevention CfDCa. Understanding Drug Overdoses and Deaths. 2022. Available from: https:\/\/www.cdc.gov\/drugoverdose\/epidemic\/index.html [Last accessed: December27 2022]."},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajad.12188"},{"issue":"4","key":"e_1_3_4_5_2","first-page":"704","article-title":"Family burden with substance dependence: A study from India","volume":"137","author":"Mattoo SK","year":"2013","unstructured":"Mattoo SK, , Nebhinani N, , Kumar BN, et al. Family burden with substance dependence: A study from India. Indian J Med Res, 2013; 137(4):704\u2013711.","journal-title":"Indian J Med Res"},{"key":"e_1_3_4_6_2","unstructured":"Advisers CoE. The Underestimated Cost of the Opioid Crisis. 2017; pp. 1\u201312. Available from: www.whitehouse.gov\/cea [Last accessed: May15 2023]."},{"key":"e_1_3_4_7_2","unstructured":"Prevention CfDCa. Wide-Ranging Online Data for Epidemiologic Research (WONDER). Available from: https:\/\/wonder.cdc.gov\/"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.13358"},{"key":"e_1_3_4_9_2","unstructured":"Prevention CfDCa. About OD2A. 2021. Available from: https:\/\/www.cdc.gov\/drugoverdose\/od2a\/about.html [Last accessed: December27 2022]."},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2017.4055"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001266"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.3694"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/d41586-019-02682-6"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11999.0000000000000292"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0000000000000753"},{"key":"e_1_3_4_16_2","unstructured":"Services USDoHH. Trump Administration Announces $1.8 Billion in Funding to States to Continue Combating Opioid Crisis. Available from: www.healthcarefinancenews.com\/news\/trump-administration-announces-18-billion-funding-states-combat-opioid-crisis [Last accessed: December27 2022]."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-021-06831-4"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2020.5446"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2019.112642"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2015.02.020"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2012.07.007"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0000000000007782"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-022-02413-3"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S135316"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2015.11.001"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.2013.834045"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1037\/amp0000655"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2019.06.003"},{"key":"e_1_3_4_29_2","first-page":"e7","article-title":"Analgesic eyedrops reduce opioid demand after strabismus surgery","volume":"22","author":"Saunte J","year":"2018","unstructured":"Saunte J, , Hansen A, , Jensen L, et al. Analgesic eyedrops reduce opioid demand after strabismus surgery. J Am Assoc Pediatr Ophthalmol Strab, 2018; 22:e7; doi: 10.1016\/j.jaapos.2018.07.018","journal-title":"J Am Assoc Pediatr Ophthalmol Strab"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.4103\/ijo.IJO_1905_18"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaophthalmol.2019.4432"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(00)00359-6"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11051424"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.004"},{"issue":"8","key":"e_1_3_4_35_2","first-page":"153","article-title":"Opioids for neuropathic pain","author":"McNicol ED","year":"2013","unstructured":"McNicol ED, , Midbari A, , Eisenberg E. Opioids for neuropathic pain. Cochrane Database Syst Rev, 2013;(8):153\u2013160; doi: 10.1002\/14651858.CD006146.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"e_1_3_4_36_2","first-page":"429","article-title":"Opioids for ocular pain\u2014A narrative review","volume":"20","author":"Pereira VB","year":"2017","unstructured":"Pereira VB, , Garcia R, , Torricelli AA, et al. Opioids for ocular pain\u2014A narrative review. Pain Phys, 2017; 20(5):429\u2013436.","journal-title":"Pain Phys"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001813"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2907"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/PHH.0000000000000894"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.2196\/17693"},{"key":"e_1_3_4_41_2","unstructured":"Bureau USC. Rural America. Available from: https:\/\/mtgis-portal.geo.census.gov\/arcgis\/apps\/MapSeries\/index.html?appid=49cd4bc9c8eb444ab51218c1d5001ef6 [Last accessed: May15 2023]."},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000228025.04535.25"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.16851"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.5694\/mja12.10168"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2008.09.009"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/pme.12659"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2008.00524.x"},{"key":"e_1_3_4_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2010.00931.x"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2021-013503"},{"key":"e_1_3_4_50_2","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.143.4.345"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1162\/ajhe_a_00113"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsurg.2017.08.023"},{"key":"e_1_3_4_53_2","unstructured":"AAMC. Addressing the Opioid Epidemic: U.S. Medical School Curricular Approaches. 2018. Available from: https:\/\/www.aamc.org\/data-reports\/analysis-brief\/report\/addressing-opioid-epidemic-us-medical-school-curricular-approaches [Last accessed: May15 2023]."},{"key":"e_1_3_4_54_2","first-page":"1","article-title":"CDC Clinical Practice Guideline for Prescribing Opioids for Pain\u2014United States, 2022","author":"Chou DDKRRCMJGTBR","year":"2022","unstructured":"Chou DDKRRCMJGTBR. CDC Clinical Practice Guideline for Prescribing Opioids for Pain\u2014United States, 2022. 2022; pp. 1\u201395. Recommendations and Reports.","journal-title":"Recommendations and Reports"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1080\/10826084.2019.1691600"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.15328"},{"issue":"5","key":"e_1_3_4_57_2","first-page":"942","article-title":"Probable relationship between opioid abuse and heroin use","volume":"67","author":"Siegal HA","year":"2003","unstructured":"Siegal HA, , Carlson RG, , Kenne DR, et al. Probable relationship between opioid abuse and heroin use. Am Fam Phys, 2003; 67(5):942\u2013945.","journal-title":"Am Fam Phys"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002623"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.06.019"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2023.0078","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0078","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:45:54Z","timestamp":1777646754000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2023.0078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,1]]},"references-count":58,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,1]]}},"alternative-id":["10.1089\/jop.2023.0078"],"URL":"https:\/\/doi.org\/10.1089\/jop.2023.0078","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,1]]}}}